SOURCE: Wall Street Equity Research

Wall Street Equity Research

August 27, 2010 09:05 ET

Analyst Study on Boston Scientific and Becton, Dickinson and Co. -- Trifecta Hurts Med Tech Industry

JOHANNESBURG, SOUTH AFRICA--(Marketwire - August 27, 2010) - brings investors market knowledge on the aspects moving the medical instruments & supplies stocks, and offers complete analytical research on companies like Boston Scientific Corporation (NYSE: BSX) and Becton, Dickinson and Company (NYSE: BDX). Register with today to gain full access to our complimentary research on these the medical instruments & supplies stocks.

The medical technology industry is down despite its history of solid recession performances. The non-cyclical nature of the industry has enabled it to weather tumultuous economic landscapes. However, the normally stable industry is down due to the unfortunately timed convergence of three detrimental factors: unemployment, vacations and underperforming industry leaders. is a specialized website where investors can have specific access to complimentary reports on the medical instruments & supplies industry; traders looking for analysis on Boston Scientific Corporation, Becton, Dickinson and Company and other players in the industry are welcomed to sign up for free at

The recent spike in unemployment has made many patients reluctant to dole out of pocket expenses for medical devices. To compensate, some companies are lowering device prices, narrowing profit margins in the process and further exacerbating the issues facing the industry. Visit us at to understand the catalysts and forces driving or affecting companies in the medical instruments & supplies industry.

Summer vacations similarly affect medical technology companies like unemployment but to a slightly lesser degree. Patients are more likely to delay procedures during the summer vacation season. 

The recent underperformance of some industry leaders has made waves that would otherwise be ripples had the timing been different. Typically, underperformances like this would not create as much apprehension as it is now but the fear of a double dip recession has made the stock market much more volatile. 

The ill-timed Trifecta of factors has halted growth for the moment but the normally resilient industry could rebound in the coming months. 

For this second quarter 2010, Boston Scientific Corporation released its financial results with profits tumbling as much as 38% to $98 million from $158 million during the same quarter in 2009. The slump in profit was largely due to a 24% slide in sales of its defibrillator system. Investors can register today at to download the full report on Boston Scientific Corporation.

On the other hand, Becton, Dickinson and Company posted revenue of $1.878 billion for the quarter with international revenue taking the lion's share boosted by continued strength in emerging economies. Investors can access free research on Becton, Dickinson and Company now by signing up at,DickinsonandCompany(BDX)270810.php.

About Wall Street Equity Research:
Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information